FOXO4-DRI as distributed by Peptides Lab UK is not intended for, and must not be used for, human consumption, medical treatment, self-administration, veterinary applications, or any use outside of a controlled laboratory environment
This distinguishes it from better-known compounds such as semaglutide (Ozempic/Wegovy), which targets only the GLP-1 receptor, and from tirzepatide (Mounjaro/Zepbound), which is a dual GLP-1/GIP agonist
The Use of Low-Dose Naltrexone for Chronic Pain Kirbie M Bostick, Andrew G McCarter, Diane Nykamp PMID: 30821677 DOI: 10.4140/TCP.n.2019.43 Review:Med Sci (Basel) 2018 Sep 21;6(4):82
Migration and accumulation of inflammatory cells in the epidermis destroyes the basal membrane and desmosomes
Verify the seller is reputable